Search Results

There are 15735 results for: content related to: Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease

  1. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1607–1614, Tom J.G. Gevers, Jeroen C. Hol, René Monshouwer, Helena M. Dekker, Jack F.M. Wetzels and Joost P.H. Drenth

    Version of Record online : 1 DEC 2014, DOI: 10.1111/liv.12726

  2. You have free access to this content
    Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 591–598, M. K. Neijenhuis, T. J. G. Gevers, F. Nevens, M. C. Hogan, V. E. Torres, W. Kievit and J. P. H. Drenth

    Version of Record online : 1 JUL 2015, DOI: 10.1111/apt.13301

  3. Polycystic liver disease: Quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts

    Hepatology

    Volume 8, Issue 6, November/December 1988, Pages: 1627–1634, Dr. Gregory T. Everson, Ann Scherzinger, Nancy Berger-Leff, Juerg Reichen, Dennis Lezotte, Michael Manco-Johnson and Patricia Gabow

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840080626

  4. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease

    Hepatology

    Volume 11, Issue 6, June 1990, Pages: 1033–1037, Patricia A. Gabow, Ann M. Johnson, William D. Kaehny, Michael L. Manco-Johnson, Irene T. Duley and Gregory T. Everson

    Version of Record online : 6 DEC 2005, DOI: 10.1002/hep.1840110619

  5. You have free access to this content
    Interventions for preventing the progression of autosomal dominant polycystic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Marinella Ruospo, Carmine Zoccali, Jonathan C Craig and Giovanni FM Strippoli

    Published Online : 14 JUL 2015, DOI: 10.1002/14651858.CD010294.pub2

  6. Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis

    Liver International

    Volume 36, Issue 4, April 2016, Pages: 595–602, Tom J.G. Gevers, Frederik Nevens, Vicente E. Torres, Marie C. Hogan and Joost P.H. Drenth

    Version of Record online : 9 NOV 2015, DOI: 10.1111/liv.12986

  7. You have free access to this content
    Systematic review: the pathophysiology and management of polycystic liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 7, October 2011, Pages: 702–713, F. Temmerman, L. Missiaen, B. Bammens, W. Laleman, D. Cassiman, C. Verslype, J. van Pelt and F. Nevens

    Version of Record online : 26 JUL 2011, DOI: 10.1111/j.1365-2036.2011.04783.x

  8. Congenital Conditions

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Jean-Pierre Benhamou, Valérie Vilgrain, Valérie Vilgrain, Valérie Vilgrain, Valérie Vilgrain, Valérie Vilgrain, Jean-Pierre Benhamou, Jean-Pierre Benhamou, Jean-François Cadranel, Pages: 779–809, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch8a

  9. Abdominal sonographic study of autosomal dominant polycystic kidney disease

    Journal of Clinical Ultrasound

    Volume 28, Issue 6, July/August 2000, Pages: 277–282, Carlos Nicolau, Roser Torra, Luis Bianchi, Ramón Vilana, Rosa Gilabert, Alejandro Darnell and Concepció Brú

    Version of Record online : 20 JUN 2000, DOI: 10.1002/1097-0096(200007/08)28:6<277::AID-JCU2>3.0.CO;2-L

  10. You have free access to this content
    The long-term outcome of patients with polycystic liver disease treated with lanreotide

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 2, January 2012, Pages: 266–274, M. Chrispijn, F. Nevens, T. J. G. Gevers, R. Vanslembrouck, M. G. H. van Oijen, W. Coudyzer, A. L. Hoffmann, H. M. Dekker, R. A. de Man, L. van Keimpema and J. P. H. Drenth

    Version of Record online : 24 NOV 2011, DOI: 10.1111/j.1365-2036.2011.04923.x

  11. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease

    Liver International

    Volume 29, Issue 9, October 2009, Pages: 1389–1395, Esmé Waanders, Loes Van Keimpema, Johannes T. Brouwer, Martijn G. H. Van Oijen, Raymond Aerts, Fred C. G. J. Sweep, Frederik Nevens and Joost P. H. Drenth

    Version of Record online : 9 JUN 2009, DOI: 10.1111/j.1478-3231.2009.02055.x

  12. You have free access to this content
    Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases

    Hepatology

    Volume 58, Issue 1, July 2013, Pages: 409–421, Tatyana V. Masyuk, Brynn N. Radtke, Angela J. Stroope, Jesús M. Banales, Sergio A. Gradilone, Bing Huang, Anatoliy I. Masyuk, Marie C. Hogan, Vicente E. Torres and Nicholas F. LaRusso

    Version of Record online : 6 MAR 2013, DOI: 10.1002/hep.26140

  13. You have free access to this content
    Polycystic disease of the liver

    Hepatology

    Volume 40, Issue 4, October 2004, Pages: 774–782, Gregory T. Everson, Matthew R. G. Taylor and R. Brian Doctor

    Version of Record online : 7 MAR 2007, DOI: 10.1002/hep.1840400404

  14. Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1578–1583, Titus F. M. Wijnands, Myrte K. Neijenhuis, Wietske Kievit, Frederik Nevens, Marie C. Hogan, Vicente E. Torres, Tom J. G. Gevers and Joost P. H. Drenth

    Version of Record online : 9 JAN 2014, DOI: 10.1111/liv.12430

  15. Surgical management of cystic lesions in the liver

    ANZ Journal of Surgery

    Volume 83, Issue 7-8, July-August 2013, Pages: E3–E20, Giuseppe Garcea, Arumugam Rajesh and Ashley R. Dennison

    Version of Record online : 26 APR 2012, DOI: 10.1111/j.1445-2197.2012.06096.x

  16. You have free access to this content
    Clinical profile of autosomal dominant polycystic liver disease

    Hepatology

    Volume 37, Issue 1, January 2003, Pages: 164–171, Qi Qian, Airong Li, Bernard F. King, Patrick S. Kamath, Donna J. Lager, John Huston III, Clarence Shub, Sonia Davila, Stefan Somlo and Vicente E. Torres

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2003.50006

  17. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease

    Liver International

    Volume 33, Issue 6, July 2013, Pages: 914–925, Paolo Onori, Romina Mancinelli, Antonio Franchitto, Guido Carpino, Anastasia Renzi, Stefania Brozzetti, Julie Venter, Heather Francis, Shannon Glaser, Douglas M. Jefferson, Gianfranco Alpini and Eugenio Gaudio

    Version of Record online : 25 APR 2013, DOI: 10.1111/liv.12177

  18. You have free access to this content
    New treatments for autosomal dominant polycystic kidney disease

    British Journal of Clinical Pharmacology

    Volume 76, Issue 4, October 2013, Pages: 524–535, Ming-Yang Chang and Albert C. M. Ong

    Version of Record online : 24 SEP 2013, DOI: 10.1111/bcp.12136

  19. Functional similarities of hepatic cystic and biliary epithelium: Studies of fluid constituents and in vivo secretion in response to secretin

    Hepatology

    Volume 11, Issue 4, April 1990, Pages: 557–565, Gregory T. Everson, Merrill Emmett, William R. Brown, Paul Redmond and David Thickman

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840110406

  20. Polycystic liver diseases

    Textbook of Clinical Gastroenterology and Hepatology, Second Edition

    Luca Fabris, Catherine McCrann, Mario Strazzabosco, Pages: 713–718, 2012

    Published Online : 16 APR 2012, DOI: 10.1002/9781118321386.ch96